Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acrivon Therapeutics Inc (ACRV)

Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 192,732
  • Shares Outstanding, K 31,136
  • Annual Sales, $ 0 K
  • Annual Income, $ -60,390 K
  • EBIT $ -85 M
  • EBITDA $ -88 M
  • 60-Month Beta 0.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.66
  • Number of Estimates 5
  • High Estimate -0.56
  • Low Estimate -0.81
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +23.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.81 +1.89%
on 12/27/24
7.82 -24.30%
on 12/02/24
-1.60 (-21.28%)
since 11/27/24
3-Month
5.81 +1.89%
on 12/27/24
8.74 -32.27%
on 11/07/24
-1.24 (-17.32%)
since 09/27/24
52-Week
3.19 +85.58%
on 02/13/24
11.90 -50.25%
on 04/09/24
+0.91 (+18.16%)
since 12/27/23

Business Summary

Acrivon Therapeutics Inc. is a clinical stage biopharmaceutical company developing precision oncology medicines which matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing Acrivon's proprietary proteomics-based patient responder identification platform,...

See More

Key Turning Points

3rd Resistance Point 6.85
2nd Resistance Point 6.62
1st Resistance Point 6.27
Last Price 5.92
1st Support Level 5.69
2nd Support Level 5.46
3rd Support Level 5.11

See More

52-Week High 11.90
Fibonacci 61.8% 8.57
Fibonacci 50% 7.55
Fibonacci 38.2% 6.52
Last Price 5.92
52-Week Low 3.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar